QualityStocksNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Spot Therapeutics Receives Health Canada Cultivation License, Triggering Long-Term Cash Flow
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. Per the update, the newly licensed facility will operate under the flagship Tweed banner, and the cultivation license initiates a long-term (25-year) cash flow stream anticipated to be approximately $2.85 million per year with commencement expected to begin in September 2019. “The long-term income stream from Spot, combined with our existing royalty portfolio, will further stabilize Canopy Rivers’ operating cash flow profile and…